DOI QR코드

DOI QR Code

Study on Distribution of Yeast Isolated from Clinical Specimens for Six Years in a University-affiliated Hospital

일개 대학병원의 임상검체에서 분리된 6년간의 효모균 분포에 관한 연구

  • Ma, Pan-Gon (Dept. of Biomedical Laboratory Science, Daegu Health Science College) ;
  • Kim, Sun-Joo (Dept. of Laboratory Medicine, Gyeongsang National University School of Medicine) ;
  • Seo, Choong-Won (Dept. of Biomedical Laboratory Science, Songho College) ;
  • Yu, Young-Bin (Dept. of Biomedical Laboratory Science, Konyang University) ;
  • Kim, Young-Kwon (Dept. of Biomedical Laboratory Science, Konyang University)
  • 마판곤 (대구보건대학교 임상병리과) ;
  • 김선주 (경상대학교 의과대학 진단검사의학교실) ;
  • 서충원 (송호대학교 임상병리과) ;
  • 유영빈 (건양대학교 임상병리학과) ;
  • 김영권 (건양대학교 임상병리학과)
  • Received : 2015.07.12
  • Accepted : 2015.09.20
  • Published : 2015.09.28

Abstract

We investigated the prevalence of fungi isolated from a university-affiliated hospital during 6 years (2006-2011) to provide relevent information for the patient management. The general characteristics of the clinical isolates and gender, age, and type of specimens were analyzed. Among a total of 163,530 requested samples to culture for the Laboratory of Clinical Microbiology, Department of Laboratory Medicine, Gyeongsang National University Hospital in the Republic of Korea, 5,387 (3.3%) showd positive results for fungi. The most prevalent isolates were Candida albicans 41.9%, Candida glabrata 15.5%, and Candida tropicalis 14.6%. Total isolates of fungi increased from 526 in 2006 to 1,145 in 2011. They were most commonly isolated from sixties (27.0%) and seventies (26.5%). The most common clinical specimen was urine (44.8%). Males (52.4%) were slightly more than females (47.6%). In the future, a nationwide survey and additional antifungal convergence drugs susceptibility results will provide more useful information.

Keywords

Candida albicans;prevalence of fungi;clinical isolates;type of specimens;antifungal convergence drugs susceptibility

References

  1. J. Akansa, J. Shubham, and R. Swati. Emerging fungal infections among children:A review on its clinical manifestations, diagnosis, and prevention, Vol. 2, pp. 314-320, 2010.
  2. J. S. Lee, J. H. Shin, and K. Lee, Species distribution and susceptibility to azole antifungals of Candida bloodstream isolates from eight university hospitals in Korea. Yonsei Med J, Vol. 48, pp. 779-86, 2007. https://doi.org/10.3349/ymj.2007.48.5.779
  3. H. S. Shin, Y. B. Park, and D. S. Shin. Isolation Frequency of Candida species from Clinical Specimens. Kor J Mycol, Vol. 38, pp. 146-151, 2010. https://doi.org/10.4489/KJM.2010.38.2.146
  4. E. M. Koh, S. G. Lee, C. G. Kim, M. S. Kim, D. E. Yong, and K. W. Lee, Microorganisms Isolated from Blood Cultures and Their Antimicrobial Susceptibility Patterns At a University Hospital During 1994-2003, Korean J Lab Med, Vol. 27, pp. 265-275, 2007. https://doi.org/10.3343/kjlm.2007.27.4.265
  5. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004;39:309-17. https://doi.org/10.1086/421946
  6. Shin JH, Kim HR, Lee JN. Distribution and antifungal susceptibility of Candida species isolated from clinical specimens during the past six years. Korean J Clin Microbiol 2004;7:164-70.
  7. C. W. Seo, Y. B. Yu, K. S. Shin, Y. K. Kim. Distribution of Yeast Isolated from Clinical Specimens at a University Hospital in last Five Years. Journal of Digital Convergence, Vol. 12. No. 9, pp. 237-244, 2014.
  8. V. Kremery, and A. J. Barnes, Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance, J Hosp Infect Vol. 50, pp. 243-260, 2002; https://doi.org/10.1053/jhin.2001.1151
  9. W. E. Trick, S. K. Fridkin, J. R Edwards, R. A. Hajjeh, and R. P. Gaynes, National Nosocomial Infections Surveillance System Hospitals. Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989 -1999, Clin Infect Dis, Vol. 35, pp. 627-630, 2002. https://doi.org/10.1086/342300
  10. A. M. Tortorano, L. Caspani, A. L. Rigoni, E. Biraghi, A. Sicignano, and M. A. Viviani, Candidiasis in the intensive care unit: a 20-year survey, J Hosp Infect, Vol. 57, pp. 8-13, 2004. https://doi.org/10.1016/j.jhin.2004.01.017
  11. J. Garbino, L. Kolarova, P. Rohner, D. Lew, P. Pichna, and D. Pittet, Secular trends of candidemia over 12 years in adult patients at a tertiary care hospital. Med(Baltimore), Vol. 81, pp. 2425-33, 2002.
  12. L. Bonavina, R. Incarbone, M. Reitano, A. Tortorano, M. Viviani, and A. Peracchia, Candida colonization in patients with esophageal disease: a prospective clinical study, Dis Esophagus, Vol. 16, pp. 70-72, 2003. https://doi.org/10.1046/j.1442-2050.2003.00297.x
  13. E. J. Won, J. H. Shin, W. K. Lee, S. H. Koo, S. Y. Kim, and Y. J. Park, Distribution of Yeast and Mold Species Isolated from Clinical Specimens at 12 Hospitals in Korea during 2011, Ann Clin Microbiol, Vol. 16, No. 2, 2013.
  14. M. S. Saag, R. J. Graybill, R. A. Larsen, P. G. Pappas, J. R. Perfect, and W. G. Powderly, Practice guidelines for the management of cryptococcal disease, Clin Infect Dis, Vol. 30, pp. 710-718, 2000. https://doi.org/10.1086/313757
  15. T. G. Mitchell, and J. R. Perfect, Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans, Rev Clin Microbiol, Vol. 8, pp. 515-48, 1995.
  16. L. B. Johnson, S. F. Bradley, C. A. Kauffman. Fungaemia due to Cryptococcus laurentii and a review of non-neoformans cryptococcaemia. Mycoses Vol. 41, pp. 277-280, 1998. https://doi.org/10.1111/j.1439-0507.1998.tb00338.x
  17. V. Silva, G. Zepeda, and D. Alvareda, Nosocomial urinary tract infection due to Trichosporon asahii, First two cases in Chile, Rev Iberoam Micol, Vol. 20, pp. 21-23, 2003.